Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders

Slide: 17 of 36

Key Questions 3–7

KQ 3: Are there any identifiable changes early in the treatment phase that predict treatment outcomes?

KQ 4: What is the evidence that effects measured at the end of the treatment phase predict long-term functional outcomes?

KQ 5: What is the evidence that specific intervention effects measured in the treatment context generalize to other contexts (e.g., people, places, materials)?

KQ 6: What evidence supports specific components of treatment as driving outcomes, either within a single treatment or across treatments?

KQ 7: What evidence supports the use of a specific treatment approach in children under the age of 2 years who are at high risk of developing autism based upon behavioral, medical, or genetic risk factors?